Consistent with this finding, treatment with anti-PD-1 and PTP 9 significantly prolonged the survival of B16F10 tumor-bearing mice compared with mice treated with anti-PD-1 alone (Fig. 3C). This evidence concerns the gene PDCD1 and neoplasm.